Mamatha Reddy

Q: What is Mamatha Reddy email address?

Email Mamatha Reddy at mamatha.reddy@alumis.com. This email is the most updated Mamatha Reddy email found in 2026.

Q: How to contact Mamatha Reddy?

To contact Mamatha Reddy send an email to mamatha.reddy@alumis.com. (updated on October 23, 2024)

Senior Director and Head of Clinical Operations at Lycia Therapeutics | Fremont, California, United States

About Mamatha Reddy

Mamatha Reddy serves as the Director of Clinical Operations at Alumis, where she leverages over 15 years of extensive experience in the life sciences industry to drive the success of clinical trials and research initiatives. In her current role, she is the program lead for all clinical pharmacology studies related to ESK-001, particularly focusing on its application in Systemic Lupus Erythematosus (SLE). Mamatha's expertise encompasses a broad spectrum of clinical trial leadership, including clinical strategy formulation, protocol design, and operational logistics, ensuring that each study adheres to the highest standards of ICH/GCP guidelines.

Mamatha is adept at developing comprehensive strategies that encompass budget management and resource allocation, which are critical for the successful execution of clinical trials. Her solid medical knowledge and proven track record in managing clinical trial milestones enable her to align clinical operations with business needs effectively. She has demonstrated success in navigating the complexities of regulatory compliance, ensuring that all trials are conducted with the utmost integrity and adherence to applicable standards.

In addition to her operational leadership, Mamatha's skill set includes assay development, drug discovery, and a deep understanding of pharmacology and oncology. Her proficiency in molecular biology techniques such as Western blotting and immunohistochemistry further enhances her ability to oversee innovative research projects. Mamatha's commitment to excellence and her strategic vision position her as a key player in advancing Alumis' clinical programs, ultimately contributing to the development of groundbreaking therapies in the biotechnology sector.

Mamatha Reddy Work